OMEROS CORP Uncategorized Contracts & Agreements
73 Contracts & Agreements
- Credit and Guaranty Agreement, dated as of June 3, 2024, among the Company, certain subsidiaries of the Company, as guarantors, various Lenders and Wilmington Savings Fund... (Filed With SEC on June 3, 2024)
- Pledge and Security Agreement, dated as of June 3, 2024, between the Company, nura inc. and Wilmington Savings Fund Society, FSB, as Collateral Agent (Filed With SEC on June 3, 2024)
- Form of Capped Call Transaction Confirmation (Filed With SEC on August 14, 2020)
- TABLE OF CONTENTS (Filed With SEC on May 12, 2014)
- 30 SunnysideAvenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-#### (Filed With SEC on May 10, 2011)
- Life Sciences Discovery Fund LSDF 10-05 Opportunity Grant Grant Award Agreement (Filed With SEC on March 15, 2011)
- Current assets (Filed With SEC on August 10, 2010)
- 30 Sunnyside Avenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-#### (Filed With SEC on July 29, 2010)
- Current assets (Filed With SEC on May 12, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on April 12, 2010)
- FIRST AMENDMENT (Filed With SEC on March 30, 2010)
- FIRST AMENDMENT OF EXCLUSIVE TECHNOLOGY OPTION AGREEMENT (Filed With SEC on November 12, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on October 2, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on September 16, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on May 15, 2009)
- OMEROS CORPORATION (Filed With SEC on May 15, 2009)
- EXCLUSIVE TECHNOLOGY OPTION AGREEMENT (Filed With SEC on May 15, 2009)
- DATED 20 April 2007 (Filed With SEC on May 15, 2009)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on April 1, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on April 1, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on April 1, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on April 1, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
- obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201 (Filed With SEC on January 9, 2008)
